Stay Updated with the Latest Bausch Health Companies Inc. BHC.TO News in Real Time
Find BHC.TO news now at Meyka AI. Stay informed with the latest Bausch Health Companies Inc. stocks updates, including price news, market analysis, and expert insights.
Robinhood (NASDAQ: HOOD) Shares Slide 4% After Unveiling $2 Billion Convertible Notes Offering Due 2029
Robinhood shares dropped roughly 4% on June 22, 2026, after the company announced a major capital raise before market open. Robinhood Markets, Inc. (NASDAQ: HOOD) intends to offer $2.0 billion in convertible senior notes due 2029 in a private placement to qualified institutional buyers under Rule 144A. Shares traded at $108.15 on June 22, within…
SpaceX Shares Fall More Than 5% Premarket, Extending Post-IPO Pullback After Record Rally
SpaceX shares came under pressure on June 22, 2026, falling more than 5% in premarket trading after an extraordinary post-IPO rally that captured Wall Street’s attention. The stock had surged to record highs in the days following its market debut, pushing the company’s valuation to unprecedented levels. Now, investors are weighing whether the recent decline…
AbbVie to Acquire Apogee Therapeutics in $10.9 Billion Deal, Offering Nearly 50% Premium
AbbVie made a major move in the biotech sector on June 22, 2026, announcing a $10.9 billion deal to acquire Apogee Therapeutics. The transaction offers Apogee shareholders nearly a 50% premium and gives AbbVie access to a promising pipeline of immunology treatments. As competition grows in the market for inflammatory disease therapies, this acquisition could…
CRH Eyes $8 Billion Arcosa Acquisition, Potential Deal Values Target at 13.7x EBITDA
CRH made its biggest-ever acquisition official on June 22, 2026, signing a definitive agreement to acquire Arcosa, Inc. (NYSE: ACA) in an all-cash transaction. CRH will pay $150 per share in cash, with the transaction valuing Arcosa at a total enterprise value of approximately $8.5 billion, representing an acquisition multiple of 11.5x 2026E Adjusted EBITDA,…
Tesla Inc (TSLA) +1.04%: Jefferies Revises Down Target, Highlights SpaceX Tracking Stock Risk
Tesla Inc (TSLA) traded higher by about 1% in recent sessions in June 2026, even as Wall Street turned cautious. In a fresh note, Jefferies revised its price target lower and flagged new concerns around valuation pressure. The report also pointed to growing risks linked to SpaceX-related tracking stock sentiment and Elon Musk’s wider business…
Huawei’s CloudMatrix Cluster Achieves 30% Utilization After Training DeepSeek’s 1.6-Trillion-Parameter AI Model
Huawei’s AI ambitions reached a new milestone in June 2026 when reports revealed that its CloudMatrix cluster achieved 30% utilization while post-training DeepSeek V4-Pro, a massive 1.6-trillion-parameter AI model. The achievement highlights the growing capabilities of Huawei’s Ascend chip ecosystem at a time when global competition in artificial intelligence infrastructure is intensifying. As China pushes…
FTSE 100 Dips 0.07% as Political Concerns Return Despite Improved Sentiment on Hormuz Talks
The FTSE 100 edged lower on Monday as investors balanced improving news from the Middle East with renewed political uncertainty in the United Kingdom. While hopes of progress in talks over the reopening of the Strait of Hormuz helped reduce pressure on oil prices, concerns over the UK’s political outlook kept buyers cautious. The benchmark…
RVNL (NSE: RVNL) Shares Rise 3% After Winning ₹2,977 Crore NMDC Contract for Vizag Infrastructure Project
Rail Vikas Nigam Limited (RVNL) is back in the spotlight after securing a massive ₹2,977 crore contract from NMDC for a key infrastructure project in Visakhapatnam. The announcement pushed RVNL shares nearly 3% higher, reflecting strong investor confidence in the company’s expanding project pipeline. As India continues to invest heavily in transport and industrial infrastructure,…
Aurobindo Pharma (NSE: AUROPHARMA) Shares Slip Despite US FTC Approval for $250 Million Lannett Acquisition
Aurobindo Pharma shares edged lower on June 22, 2026, despite a significant regulatory win announced before market open. Aurobindo Pharma USA, a wholly-owned subsidiary, received approval from the US Federal Trade Commission to proceed with the $250 million acquisition of Lannett Company LLC on a cash-free, debt-free basis. It inclusive of normalized working capital, with…